| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 09/29/2011 | US20110237503 Novel peptides and methods for their preparation and use |
| 09/29/2011 | US20110236510 Pregnane glycoside compositions and caralluma extract products and uses thereof |
| 09/29/2011 | US20110236505 Carbohydrate bar |
| 09/29/2011 | US20110236488 Herbal formulation for prevention and treatment of diabetes and associated complications |
| 09/29/2011 | US20110236485 Shell and core dosage form approaching zero-order drug release |
| 09/29/2011 | US20110236481 Use of saffron and/or safranal and/or crocin and/or picrocrocin and/or derivatives thereof as a sateity agent for treatment of obesity |
| 09/29/2011 | US20110236479 Direct compression formulation and process |
| 09/29/2011 | US20110236477 Pharmaceutical composition, pharmaceutical dosage form, process for their preparation, methods for treating and uses thereof |
| 09/29/2011 | US20110236476 Pharmaceutical composition comprising eicosapentaenoic acid and nicotinic acid and methods of using same |
| 09/29/2011 | US20110236454 Injectable drug delivery formulation |
| 09/29/2011 | US20110236443 Multilayer melt-extruded film |
| 09/29/2011 | US20110236438 Method of treatment of diseases using hoodia extracts |
| 09/29/2011 | US20110236436 Pharmaceutical composition for modified release |
| 09/29/2011 | US20110236413 Methods and compositions to reduce fat gain, promote weight loss in animals |
| 09/29/2011 | US20110236401 Compositions and methods for modulating lymphocyte activity |
| 09/29/2011 | US20110236397 Limited proteolysis of cd2ap and progression of renal disease |
| 09/29/2011 | US20110236394 Methods for the regulation of the prostaglandin f synthase (pgfs) activity of akr1b1 and uses thereof |
| 09/29/2011 | US20110236389 Human Angiostatin Interacting and Tumor Metastasis Involving Protein Variants and Uses Thereof |
| 09/29/2011 | US20110236382 Immunosuppressive combination and its use in the treatment or prophylaxis of insulin-producing cell graft rejection |
| 09/29/2011 | US20110236370 Genetic Alterations on Chromosomes 21q, 6q and 15q and Methods of Use Thereof for the Diagnosis and Treatment of Type I Diabetes |
| 09/29/2011 | US20110236364 Compositions containing non-polar compounds |
| 09/29/2011 | US20110236358 Composition comprising isoflavones |
| 09/29/2011 | US20110236356 Methods of isolating and using stem cells |
| 09/29/2011 | US20110236352 PEGylation by the Dock and Lock (DNL) Technique |
| 09/29/2011 | US20110236340 Crosslinked cation exchange polymers, compositions and use in treating hyperkalemia |
| 09/29/2011 | US20110236317 Tetrahydrotriazine compounds for treating diseases associated with ampk acitivity |
| 09/29/2011 | DE102010012556A1 Use of glucose isomerase in treatment or diagnosis of diabetes and metabolic syndrome |
| 09/29/2011 | CA2794540A1 Methods and compositions for weight loss |
| 09/29/2011 | CA2794003A1 Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use |
| 09/29/2011 | CA2793999A1 Sarms and method of use thereof |
| 09/29/2011 | CA2793985A1 Proangiogenic compositions, method for preparing same, and uses thereof |
| 09/29/2011 | CA2793949A1 Novel spiro imidazolone derivatives as glucagon receptor antagonists, compositions, and methods for their use |
| 09/29/2011 | CA2789900A1 Pharmaceutical composition comprising a pyrimidineone derivative |
| 09/29/2011 | CA2789778A1 Cyclopentyl - and cycloheptylpyrazoles as fxr modulators |
| 09/28/2011 | EP2368988A1 Modulation of Glucocorticoid Receptor Expression |
| 09/28/2011 | EP2368910A1 An antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 09/28/2011 | EP2368909A1 GLP-1 analog fusion proteins |
| 09/28/2011 | EP2368902A2 Insulin and IGF-1 receptor agonists and antagonists |
| 09/28/2011 | EP2368898A1 Compositions and methods for counteracting effects of reactive oxygen species and free radicals |
| 09/28/2011 | EP2368887A1 1, 2, 3-triazole derivatives for use as stearoyl-COA desaturase inhibitors |
| 09/28/2011 | EP2368873A1 Improved crystalline material |
| 09/28/2011 | EP2368560A1 An anti-diabetic extract of rooibos |
| 09/28/2011 | EP2368552A1 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(r)-amino-piperidin-1-yl]-xanthine for the treatment of a metabolic disorder of a predominantly carnivorous non-human animal |
| 09/28/2011 | EP2367830A1 1-oxa-8-azaspiro [4, 5] decane- 8 -carboxamide compounds as faah inhibitors |
| 09/28/2011 | EP2367817A1 Inhibitors of diacylglycerol acyltransferase |
| 09/28/2011 | EP2367802A2 Tetrahydrotriazine compounds for treating diseases associated with ampk activity |
| 09/28/2011 | EP2367801A1 Polar quinazolines as liver x receptors ( lxrs ) modulators |
| 09/28/2011 | EP2367598A2 Inhibitors of diacylglycerol acyltransferase |
| 09/28/2011 | EP2367554A2 Bile acid recycling inhibitors for treatment of obesity and diabetes |
| 09/28/2011 | EP2367449A1 Composition comprising isoflavones |
| 09/28/2011 | EP2133335B1 Sphingosine compound, method for producing the same, and sphingomyelinase inhibitor |
| 09/28/2011 | EP2041137B1 Pyrrolopyrimidines for pharmaceutical compositions |
| 09/28/2011 | EP1962838B1 Farnesoid x receptor agonists |
| 09/28/2011 | EP1828107B1 Hydroxybiphenyl carboxylic acids and derivatives, method for producing the same and their use |
| 09/28/2011 | EP1643999B1 Pyridoxamine for use in the treatment of diabetic neprhopathy in type ii diabetes |
| 09/28/2011 | EP1617835B1 Compounds for the treatment of metabolic disorders |
| 09/28/2011 | EP1536826B1 Igf-2 peptide for use in tolerogenic approaches for type i diabetes. |
| 09/28/2011 | EP1424330B1 Activator for peroxisome proliferator-responsive receptor delta |
| 09/28/2011 | EP1421191B1 Humanised antibodies specific for both CD45RB and CD45RO |
| 09/28/2011 | EP1420800B1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at 4) receptor activity |
| 09/28/2011 | EP1237891B1 Heterocyclic dihydropyrimidines as potassium channel inhibitors |
| 09/28/2011 | CN1915981B 2-oxy-benzoxazinone derivatives for the treatment of obesity |
| 09/28/2011 | CN1646139B Use of pyrimidine nucleotides for the treatment of affections of the peripheral nervous system |
| 09/28/2011 | CN1344159B Combinations for treatment of diseases involving angiogenesis |
| 09/28/2011 | CN102203130A Glp-1 derivative and application thereof |
| 09/28/2011 | CN102203096A Compounds that expand hematopoietic stem cells |
| 09/28/2011 | CN102203074A Aryl GPR119 agonists and uses thereof |
| 09/28/2011 | CN102203059A Substituted aminoindanes and analogs thereof, and the pharmaceutical use thereof |
| 09/28/2011 | CN102202681A Neuropeptide-2-receptor (y-2r) agonists and uses thereof |
| 09/28/2011 | CN102202662A Agent for treatment of diabetes |
| 09/28/2011 | CN102202519A Method for producing lipid |
| 09/28/2011 | CN102199226A Method for extracting peanut polysaccharides from hot pressed peanut meal |
| 09/28/2011 | CN102199206A Insulin analogue having quick response and stability under acidic condition and preparation thereof |
| 09/28/2011 | CN102199171A Vanadium coordination compounds taking kojic acid derivative as ligand and preparation method and application thereof |
| 09/28/2011 | CN102199157A Bromine-containing benzopyran compound and preparation and application thereof |
| 09/28/2011 | CN102199152A Heterocycle imidazoles phosphatide kinases inhibitor |
| 09/28/2011 | CN102199151A 8-[3-amino-piperidin-1-yl]-xanthine, the production thereof and the use |
| 09/28/2011 | CN102199150A Optical active oxazolidinone derivatives as well as preparation methods and application to preparing medicaments |
| 09/28/2011 | CN102199134A Thiadiazole histone deacetylase inhibitors and application thereof |
| 09/28/2011 | CN102198250A Preparation method of traditional Chinese medicine for treating cholesterol increase disease of a yolk accumulation type |
| 09/28/2011 | CN102198233A Method for preparing Chinese medicine for treating multi-dessert type triglyceride hyperlipidemia |
| 09/28/2011 | CN102198218A Radix hedysari and cordyceps compound fine flour capsule and preparation method thereof |
| 09/28/2011 | CN102198197A Method for preparing Chinese medicine for treating area type Cholesterol increase syndrome |
| 09/28/2011 | CN102198174A Traditional Chinese medicine formulated preparation for nourishing kidney, removing heat from liver, reducing sugar and regulating fat, and preparation method thereof |
| 09/28/2011 | CN102198173A Medicine for preventing and treating diabetes and preparation method and use thereof |
| 09/28/2011 | CN102198152A Injection containing astragalus polysaccharide-iron complex for swine, and preparation method thereof |
| 09/28/2011 | CN102198151A Bulk pharmaceutical of swine astragalus polyferose and preparation method thereof |
| 09/28/2011 | CN102198116A Preparation method of vitamin A microcapsules |
| 09/28/2011 | CN102198115A Enteric-coated micro-capsule prepared by mixing traditional Chinese medicine extract and probitics |
| 09/28/2011 | CN102198103A Stable exenatide sustained-release microsphere preparation and preparation method thereof |
| 09/28/2011 | CN101983692B Medicine for treating hyperlipemia and preparation method thereof |
| 09/28/2011 | CN101961363B Preparation method of active pseudo-ginseng slices |
| 09/28/2011 | CN101849935B Sesamin/episesamin compositions |
| 09/28/2011 | CN101843587B Method for preparing ornithine aspartate powder injection for injection |
| 09/28/2011 | CN101837104B Hyperlipidemia treating capsules |
| 09/28/2011 | CN101716241B Weight-losing and fat-lowering medicinal composition and preparation method thereof |
| 09/28/2011 | CN101703637B Compound lipidol-reducing extract preparation granule and production technique thereof |
| 09/28/2011 | CN101618016B Method for preparing W/O/W type compound emulsion embedding chlorogenic acid, product and application of W/O/W type compound emulsion |
| 09/28/2011 | CN101564494B Use of traditional Chinese composition |
| 09/28/2011 | CN101491563B Ginseng and pilose antler oral preparation and preparation method thereof |